Pleural Effusion: A High-Yield USMLE Review
A pleural effusion is an abnormal accumulation of fluid in the pleural space, which normally holds only a small volume (5–15 mL) that lubricates the lung surfaces during breathing. The central exam task is distinguishing a transudate from an exudate using Light's criteria, because this dictates the entire workup and management. Effusions arise from a wide range of systemic and local diseases, and any unexplained exudative effusion should prompt consideration of malignancy.
Pathophysiology
Pleural fluid is produced primarily by the parietal pleura and is absorbed primarily via lymphatic stomata on the parietal pleura; the visceral pleura, supplied by the low-pressure pulmonary circulation, plays only a minor role. An effusion results when this balance is disrupted. Increased hydrostatic pressure (heart failure) or decreased oncotic pressure (hypoalbuminemia) drives protein-poor transudative fluid across intact capillaries; movement of low-protein ascitic fluid through diaphragmatic defects (hepatic hydrothorax) is likewise a transudate. Increased capillary permeability from infection or inflammation, lymphatic obstruction from malignancy, or inflammatory fluid tracking from the peritoneum (pancreatitis) produces protein-rich exudative fluid. The fluid displaces aerated lung, producing the characteristic dullness, absent breath sounds, and decreased fremitus.
Presentation
- Subacute, progressive dyspnea developing over days to weeks
- Diminished or absent breath sounds over the affected lung field
- Dullness to percussion over the effusion
- Decreased tactile fremitus on the affected side
- Dyspnea worse when lying flat with a large effusion; patient may prefer to lie on the affected side
- Tracheal deviation away from the affected side with a large effusion
- In malignant/mesothelioma-associated effusions: chest pain and an often bloody effusion
Diagnosis
- Chest X-ray: often the first study to reveal the effusion; may also show an associated mass, consolidation, or hilar enlargement
- Thoracentesis: diagnostic sampling of pleural fluid to apply Light's criteria and classify transudate vs. exudate; essential to characterize any unexplained effusion
- Pleural fluid analysis in the parapneumonic setting — pH, glucose, LDH, appearance, and Gram stain/culture — differentiates uncomplicated (pH >7.2, glucose >60, clear fluid, negative culture), complicated (pH <7.2, glucose <60, elevated LDH, turbid, positive Gram stain/culture — drainage required), and empyema (frank pus in the pleural space)
- CT chest with contrast for exudates: better characterization and evaluation for malignancy or pleural thickening/nodularity (mesothelioma)
- Cytology from thoracentesis confirms malignant effusion, which in lung cancer denotes stage IV disease
Management
- Determine transudate vs. exudate first — this drives everything
- Transudate: treat the underlying systemic disease (e.g., diuresis for CHF; diuresis and TIPS for refractory hepatic hydrothorax; treat nephrotic syndrome); pleural procedures such as pleurodesis are generally not indicated and repeated drainage is rarely needed once the cause is controlled
- Exudate: identify and treat the local cause and drain when indicated
- Uncomplicated parapneumonic effusion: antibiotics alone with serial imaging
- Complicated parapneumonic effusion: chest tube drainage required in addition to antibiotics
- Empyema: urgent drainage; VATS may be needed for loculated collections
- Malignant effusion: palliative drainage with an indwelling catheter or pleurodesis
- Tuberculous effusion: anti-TB therapy (adjunctive steroids controversial); RA/SLE effusions: treat the underlying disease and drain if symptomatic
High-yield
- Light's criteria distinguish transudate from exudate — the first question in any effusion
- Transudate = treat the systemic disease; exudate = treat the local disease and consider drainage
- Always consider malignancy in an unexplained exudative effusion
- Classic exam triad on the affected side: dullness to percussion, absent/diminished breath sounds, and decreased tactile fremitus
- A large effusion deviates the trachea AWAY from the affected side (contrast with volume loss/atelectasis, which pulls it toward)
- A new pleural effusion in a pneumonia patient failing antibiotics → thoracentesis to evaluate for complicated parapneumonic effusion or empyema
- Malignant pleural effusion in lung cancer = stage IV disease
- Mesothelioma: strong asbestos association, long latency (20–40 years), NOT related to smoking; presents with insidious dyspnea, chest pain, and an often bloody effusion
- Transudate causes: heart failure, cirrhosis (hepatic hydrothorax), nephrotic syndrome (systemic factors)
Pitfalls
- Confusing effusion with pneumothorax — both cause absent breath sounds, but effusion is DULL to percussion whereas pneumothorax is hyperresonant
- Treating a transudative effusion with pleurodesis or repeated drainage instead of addressing the underlying systemic disease
- Mislabeling hepatic hydrothorax (a transudate that tracks from ascites through diaphragmatic defects) as an exudate — only pancreatitis-related peritoneal fluid produces an exudative effusion
- Failing to perform thoracentesis in a pneumonia patient who develops a new effusion while on appropriate antibiotics, missing a complicated effusion or empyema that needs drainage
- Managing a complicated parapneumonic effusion or empyema with antibiotics alone — these require drainage
- Anchoring on infection and overlooking malignancy as a cause of an unexplained exudative effusion
Don't just memorize Pleural Effusion — practice reasoning through it on branching cases where your decisions shape the patient.